Health Care & Life Sciences » Pharmaceuticals | Biofermin Pharmaceutical Co. Ltd.

Biofermin Pharmaceutical Co. Ltd.

Biofermin Pharmaceutical Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY192.6
Market Cap
JPY27.43 B
Shares Outstanding
12.15 M
Public Float
3.84 M

Profile

Address
Sannomiya Central Building, 12/F
Kobe Hyogo 650
Japan
Employees -
Website http://www.biofermin.co.jp
Updated 07/08/2019
Biofermin Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products, quasi-drugs, veterinary drugs, agrichemicals, cosmetics, medical equipment, foods, beverages, food additives, feeds, feed additives and other chemicals. Its products include pharmaceutical items such as New Biofermin S, Biofermin Antidiarrheal, Biofermin, Stomachic Tablets, Biofermin VC, Biofermin Laxatives, Biofermin R, etc. It also provides various clinical test services.

Financials

View All
Created with Highcharts 5.0.14Biofermin Pharmaceutical Co. Ltd.Net Income. Fiscal year is April-March. All values JPY Millions.2 1622 1622 2762 2761 5901 5901 8991 8992 2112 2112 3052 30520142015201620172018201905001000150020002500
Created with Highcharts 5.0.14Biofermin Pharmaceutical Co. Ltd.Sales/Revenue. Fiscal year is April-March. All values JPY Millions.10 53310 53310 84610 8469 6669 66610 61910 61910 87710 87711 54311 54320142015201620172018201902.5k5k7.5k10k12.5k

Hisataka Hotta
Chairman
Takaaki Fujimoto
President & Representative Director